Претраживање
Приказ резултата 1-10 од 108
Significance of new prognostic markers in early stage chronic lymphocytic leukemia patients
(Elsevier, Amsterdam, 2011)
Thrombosis and pregnancy in hereditary thrombophilias
(Wiley-Blackwell, Hoboken, 2011)
Is miR-133a marker of progressive chronic kidney disease?
(Oxford University Press, 2019)
Chronic kidney disease (CKD) is associated with a high incidence of cardiovascular (CV) disease and numerous risk factor have been implicated to play a role. Recent studies have shown that the levels of various microRNAs ...
Clinical characteristics of the first thrombosis process among young women and those over 45 years
(Pergamon-Elsevier Science Ltd, Oxford, 2013)
A novel prothrombin c.1787G gt A mutation in Serbian family with recurrent thromboembolism-another case of antithrombin resistance
(Wiley-Blackwell, Hoboken, 2013)
Obstacles in the Diagnostics and Therapy of Heparin-Induced Thrombocytopenia
(Srpsko lekarsko društvo, Beograd, 2010)
An immune-mediated, severe, acquired prothrombotic disorder, heparin-induced thrombocytopenia type II (HIT II) occurs in 0.5-5% of patients exposed to unfractionated heparin longer than 5-7 days. Arterial and venous ...
Clinical and biological characteristics of IDH1 and 2 mutations in acute myeloid leukemia patients with normal karyotype (nc-aml) in Serbia
(Ferrata Storti Foundation, Pavia, 2013)
High resolution cytogenetic mapping and whole exome sequencing reveal a complex pattern of chromosome 6p aberrations in patients with myeloid malignancies
(Ferrata Storti Foundation, Pavia, 2015)
Thrombin Activatable Fibrinolysis Inhibitor (TAFI): A Molecular Link Between Coagulation and Fibrinolysis
(Srpsko lekarsko društvo, Beograd, 2010)
Although the maintenance of precise balance between coagulation and fibrinolysis is of utmost importance for normal haemostasis, until recently these two systems were considered as completely separate mechanisms involved ...